BioPharma Credit PLC (LON: BPCR)
London
· Delayed Price · Currency is GBP · Price in USD
0.856
+0.004 (0.42%)
Jan 23, 2025, 12:30 PM BST
BioPharma Credit Revenue
BioPharma Credit had revenue of $79.15M USD in the half year ending June 30, 2024, with 4.22% growth. This brings the company's revenue in the last twelve months to $136.37M, down -38.22% year-over-year. In the year 2023, BioPharma Credit had annual revenue of $135.74M, down -37.78%.
Revenue (ttm)
$136.37M
Revenue Growth
-38.22%
P/S Ratio
7.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
820.24M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
HSBC Holdings | 43.25B |
London Stock Exchange Group | 8.59B |
Barclays | 23.60B |
Lloyds Banking Group | 18.56B |
3i Group | 4.29B |
NatWest Group | 13.99B |
Standard Chartered | 13.78B |
Prudential | 8.66B |